Beta-carotene and lung cancer: a case study

Area of Science:

• Nutritional Epidemiology
• Public Health Nutrition
• Cancer Prevention Research

Background:

• Conflicting evidence exists regarding beta-carotene and lung cancer risk.
• Dietary intake of beta-carotene, particularly from fruits and vegetables, has been associated with lower lung cancer rates.
• Beta-carotene supplementation trials have yielded contradictory results.

Purpose of the Study:

• To review available evidence on the relationship between beta-carotene and lung cancer.
• To discuss the implications of this evidence for nutrition recommendations.
• To evaluate the role of different evidence types in public health guidance.

Main Methods:

• Review of observational studies (case-control and cohort) on beta-carotene intake, status, and lung cancer.
• Analysis of intervention trial data on beta-carotene supplementation and lung cancer incidence.
• Synthesis of evidence to inform nutrition recommendations.

Main Results:

• Observational studies suggest a lower lung cancer risk with higher intake of beta-carotene-rich foods and higher blood beta-carotene levels.
• Large intervention trials indicate that beta-carotene supplementation does not prevent lung cancer and may increase risk in smokers.
• Supplementation showed adverse effects, including increased lung cancer incidence and mortality in smokers.

Conclusions:

• Caution is warranted when recommending beta-carotene supplements, especially for smokers.
• Evidence does not support changing fruit and vegetable recommendations towards specific nutrient supplementation.
• Randomized intervention trials are crucial before establishing public health recommendations for micronutrient supplementation.